$BNAI
Brand Engagement Network Inc.

2023 Q3 Form 10-Q Financial Statement

#000119312523277118 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3
Revenue $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $75.45K
YoY Change
% of Gross Profit
Depreciation & Amortization $209.7K
YoY Change
% of Gross Profit
Operating Expenses $1.620M
YoY Change -38.17%
Operating Profit -$1.624M
YoY Change -38.01%
Interest Expense $570.0K
YoY Change -59.19%
% of Operating Profit
Other Income/Expense, Net $34.32K
YoY Change -96.4%
Pretax Income -$1.590M
YoY Change -4.55%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.590M
YoY Change -4.55%
Net Earnings / Revenue
Basic Earnings Per Share -$0.12
Diluted Earnings Per Share -$0.13
COMMON SHARES
Basic Shares Outstanding 22.41M shares
Diluted Shares Outstanding 22.41M shares

Balance Sheet

Concept 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.0K
YoY Change -71.38%
Cash & Equivalents $60.85K
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $86.34K
YoY Change -91.67%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $49.20M
YoY Change -84.2%
Total Long-Term Assets $49.20M
YoY Change -84.2%
TOTAL ASSETS
Total Short-Term Assets $86.34K
Total Long-Term Assets $49.20M
Total Assets $49.28M
YoY Change -84.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.200M
YoY Change 33.88%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.737M
YoY Change 43.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $12.10M
YoY Change -3.01%
Total Long-Term Liabilities $12.10M
YoY Change -3.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.737M
Total Long-Term Liabilities $12.10M
Total Liabilities $19.88M
YoY Change 11.37%
SHAREHOLDERS EQUITY
Retained Earnings -$19.80M
YoY Change 17.73%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$19.80M
YoY Change
Total Liabilities & Shareholders Equity $49.28M
YoY Change -84.22%

Cashflow Statement

Concept 2023 Q3
OPERATING ACTIVITIES
Net Income -$1.590M
YoY Change -4.55%
Depreciation, Depletion And Amortization $209.7K
YoY Change
Cash From Operating Activities -$250.0K
YoY Change 344.84%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 280.0K
YoY Change
NET CHANGE
Cash From Operating Activities -250.0K
Cash From Investing Activities 0.000
Cash From Financing Activities 280.0K
Net Change In Cash 30.00K
YoY Change -153.38%
FREE CASH FLOW
Cash From Operating Activities -$250.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001838163
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40130
dei Entity Registrant Name
EntityRegistrantName
DHC ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1574798
dei Entity Address Address Line1
EntityAddressAddressLine1
1900 West Kirkwood Blvd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1400B
dei Entity Address City Or Town
EntityAddressCityOrTown
Southlake
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
76092
dei City Area Code
CityAreaCode
214
dei Local Phone Number
LocalPhoneNumber
452-2300
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
dhcau Number Of Days After Consummation Of Business Combination Within Which Securities Shall Be Registered With Securities Exchange Commission
NumberOfDaysAfterConsummationOfBusinessCombinationWithinWhichSecuritiesShallBeRegisteredWithSecuritiesExchangeCommission
P20D
dhcau Number Of Days Related To Payment To Acquire Restricted Investment
NumberOfDaysRelatedToPaymentToAcquireRestrictedInvestment
P2D
dhcau Number Of Days For Consummation Of Business Combination
NumberOfDaysForConsummationOfBusinessCombination
P10D
CY2023Q3 us-gaap Cash
Cash
60847
CY2022Q4 us-gaap Cash
Cash
212608
CY2023Q3 dhcau Due From Related Party Current
DueFromRelatedPartyCurrent
3000
CY2022Q4 dhcau Due From Related Party Current
DueFromRelatedPartyCurrent
1500
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22494
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
61530
CY2023Q3 us-gaap Assets Current
AssetsCurrent
86341
CY2022Q4 us-gaap Assets Current
AssetsCurrent
275638
CY2023Q3 us-gaap Accounts Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent
AccountsReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent
16824
CY2023Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
49179344
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
313913217
CY2023Q3 us-gaap Assets
Assets
49282509
CY2022Q4 us-gaap Assets
Assets
314188855
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7162387
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5440933
CY2023Q3 dhcau Advances From Related Party Current
AdvancesFromRelatedPartyCurrent
575000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7737387
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5440933
CY2023Q3 dhcau Warrant Liabilities Non Current
WarrantLiabilitiesNonCurrent
1315283
CY2022Q4 dhcau Warrant Liabilities Non Current
WarrantLiabilitiesNonCurrent
164410
CY2023Q3 dhcau Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
10830775
CY2022Q4 dhcau Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
10830775
CY2023Q3 us-gaap Liabilities
Liabilities
19883445
CY2022Q4 us-gaap Liabilities
Liabilities
16436118
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
49196168
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
313913217
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-18904696
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19797878
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16161254
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-19797104
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-16160480
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49282509
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
314188855
CY2023Q3 dhcau Operating And Formation Costs
OperatingAndFormationCosts
1624228
CY2022Q3 dhcau Operating And Formation Costs
OperatingAndFormationCosts
2620236
dhcau Operating And Formation Costs
OperatingAndFormationCosts
2485751
dhcau Operating And Formation Costs
OperatingAndFormationCosts
4566572
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1624228
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2620236
us-gaap Operating Income Loss
OperatingIncomeLoss
-2485751
us-gaap Operating Income Loss
OperatingIncomeLoss
-4566572
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
539266
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
442264
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1150873
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6655331
CY2023Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
573581
CY2022Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1396729
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3868445
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1844800
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34315
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
954465
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2717572
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8500131
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1589913
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1665771
us-gaap Net Income Loss
NetIncomeLoss
231821
us-gaap Net Income Loss
NetIncomeLoss
3933559
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-16160480
CY2023Q1 dhcau Adjustments To Additional Paid In Capital Shareholder Non Redemption Agreement
AdjustmentsToAdditionalPaidInCapitalShareholderNonRedemptionAgreement
-744274
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
744274
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2775554
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2078069
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-16857965
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
519310
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-256335
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-17633610
CY2023Q3 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
573581
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1589913
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-19797104
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2830646
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-16074050
CY2022Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
448071
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2768684
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-13753437
CY2022Q3 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1396729
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1665771
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-16815937
us-gaap Profit Loss
ProfitLoss
231821
us-gaap Profit Loss
ProfitLoss
3933559
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3868445
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1844800
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1150873
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6655331
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
1500
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
1500
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-39036
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
297464
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1721454
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4353509
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-726761
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-512027
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
268602318
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
0
us-gaap Payments To Acquire Receivables
PaymentsToAcquireReceivables
16824
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
268585494
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
575000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
268585494
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-268010494
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-151761
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-512027
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
212608
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
861474
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60847
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
349447
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2020-12-22
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
300000000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
9450720
CY2023Q3 dhcau Assets Deposited In Trust Noncurrent
AssetsDepositedInTrustNoncurrent
309450720
CY2023Q3 dhcau Transaction Cost
TransactionCost
17501346
CY2021Q1 dhcau Cash Underwriting Fess Net Of Reimbursement
CashUnderwritingFessNetOfReimbursement
6189014
CY2023Q3 dhcau Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
10830775
CY2023Q3 dhcau Other Offering Costs Payable
OtherOfferingCostsPayable
481557
CY2023Q3 dhcau Percentage Of Asset Held In Trust Account
PercentageOfAssetHeldInTrustAccount
0.80
CY2023Q3 dhcau Net Tangible Assets Required For Consummation Of Business Combination
NetTangibleAssetsRequiredForConsummationOfBusinessCombination
5000001
dhcau Dissolution Expenses
DissolutionExpenses
100000
CY2023Q3 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2023Q3 us-gaap Cash
Cash
60847
CY2023Q3 dhcau Working Capital
WorkingCapital
7651046
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One <div style="display:inline;">of </div>the more significant accounting estimates included in these unaudited condensed consolidated financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates. </div>
dhcau Future Confirming Events
FutureConfirmingEvents
one or more future confirming events
dhcau Term Of Short Term Investments
TermOfShortTermInvestments
P3M
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Accounts Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent
AccountsReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent
887555
CY2023Q3 us-gaap Accounts Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent
AccountsReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent
16824
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has historically had significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. </div>
CY2023Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
dhcau Aggregate Offering Costs Incurred
AggregateOfferingCostsIncurred
17501347
dhcau Offering Costs Charged To Temporary Equity
OfferingCostsChargedToTemporaryEquity
16915008
dhcau Offering Costs Expensed
OfferingCostsExpensed
586339
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
9450720
CY2023Q3 dhcau Assets Deposited In Trust Noncurrent
AssetsDepositedInTrustNoncurrent
309450720
dhcau Number Of Days After The Completion Of The Business Combination Termination Of The Applicable Lockup Period Occurs
NumberOfDaysAfterTheCompletionOfTheBusinessCombinationTerminationOfTheApplicableLockupPeriodOccurs
P45D
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3554928
CY2023Q3 dhcau Deferred Underwriting Fee Payable Per Unit
DeferredUnderwritingFeePayablePerUnit
0.35
CY2023Q3 dhcau Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
10830775
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
dhcau Number Of Days After Consummation Of Business Combination Within Which Securities Registration Shall Become Effective
NumberOfDaysAfterConsummationOfBusinessCombinationWithinWhichSecuritiesRegistrationShallBecomeEffective
P60D
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
313913217

Files In Submission

Name View Source Status
dhcau-20230930_cal.xml Edgar Link unprocessable
dhcau-20230930_pre.xml Edgar Link unprocessable
0001193125-23-277118-index-headers.html Edgar Link pending
0001193125-23-277118-index.html Edgar Link pending
0001193125-23-277118.txt Edgar Link pending
0001193125-23-277118-xbrl.zip Edgar Link pending
d522940d10q.htm Edgar Link pending
d522940dex311.htm Edgar Link pending
d522940dex312.htm Edgar Link pending
d522940dex321.htm Edgar Link pending
d522940dex322.htm Edgar Link pending
dhcau-20230930.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
dhcau-20230930_def.xml Edgar Link unprocessable
dhcau-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d522940d10q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending